LATEST NEWS

To fight tuberculosis, LJI scientists uncover the key immune cells in play after BCG vaccination
A "Lab Manager of the Year" finalist shares tips for keeping research running—and scientists happy
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
La Jolla Institute’s “Top Workplaces” ranking proves the power of collaboration in advancing medical research
New LJI study shows there may be a way to help even more psoriasis patients
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
The international recognition reflects how LJI research is valued by scientific peers
ARCS support propels vaccine design and HIV research
After a long week in the lab, Sundays are for sailing
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
Richard Stryjewski, a financial leader with deep expertise in the non-profit research sector, has been appointed as Chief Financial Officer at La Jolla Institute for Immunology.
Behind every “eureka!” science headline is a story of perseverance